Every 10-Q that Runway Growth Finance Corp. (RWAY) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow RWAY and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full RWAY filings page.
RWAY presents a detailed schedule of control and non-control investments across sectors such as health care equipment and services, pharmaceuticals and biotechnology, application software, technology hardware, financial services, consumer staples distribution and retail, commercial and professional services, media and entertainment, and insurance.
The portfolio includes many senior secured debt positions that reference SOFR or Prime plus a spread, with contractual rate floors and features such as PIK and ETP components; examples include loans to 4Web, Inc. at SOFR+9.25% with a 12.75% floor and 34.43% ETP, Biotricity, Inc. at SOFR+10.50% with an 11.50% floor and 10.29% ETP, and SPB C‑2024, LLC in Multi-Sector Holdings at fixed 15.00% PIK with 1.57% ETP. Alongside debt, RWAY holds numerous warrants, preferred and common equity stakes, and contractual rights such as success fees, royalties, contingent value rights, and earnouts, each with stated initial acquisition and maturity dates, with some instruments maturing as far out as 2035 and 2039.
Runway Growth Finance’s quarterly filing details a highly diversified investment portfolio made up of senior secured loans, preferred equity and warrants across software, healthcare, financial services, consumer and other sectors. Many debt positions are labeled senior secured with floating rates such as SOFR or PRIME plus sizable spreads, often with payment-in-kind (PIK) components and extra “ETP” return features, and maturities generally running from the mid‑2020s into the early 2030s.
The schedule also lists numerous warrant positions in common or preferred stock and several equity stakes, including control or significant interests in entities like Pivot3, Inc., Runway‑Cadma I LLC and Gynesonics, Inc. Overall, the table emphasizes broad sector exposure, frequent use of structured senior loans and long‑dated equity upside through warrants and preferred securities.
Runway Growth Finance Corp. filed its quarterly report for the period ended September 30, 2025, detailing a highly diversified portfolio of private company investments. The report focuses on fair value measurements for Level 3 assets, primarily non-control, non-affiliate senior secured loans and related warrants and equity positions.
The portfolio spans multiple industries including application and systems software, healthcare technology and equipment, financial services, data processing, media and entertainment, consumer staples and retail, and technology hardware. Many debt positions are structured as senior secured term loans or revolvers priced at SOFR- or PRIME-based floating rates with floors, plus payment-in-kind (PIK) and end-of-term payment (ETP) components, and long-dated maturities typically extending into 2027–2034.
The company also holds numerous warrants and preferred or common equity positions, often as success fees or earnouts tied to its lending relationships. The cover of the report notes that 36,134,037 shares of common stock were outstanding as of November 4, 2025, and that the common stock and certain notes are listed on the Nasdaq Global Select Market.